Back to calendar
Immunovant, Inc. (IMVT) Earnings
IMVT reports earnings on Wednesday, August 12, 2026
earnings report
August 12, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.62
Actual EPS: $-0.73
EPS surprise: -23.31%
Company overview
Market Cap$8.0B
PriceUSD 39.20
EPS (TTM)-2.77
52-week high41.23
52-week low14.32
SectorHealth Technology
IndustryBiotechnology
Employees315